SECOND AMENDMENT TO LEASENuvelo Inc • November 14th, 2003 • In vitro & in vivo diagnostic substances
ASSIGNMENT AND ASSUMPTION OF LEASEAssignment and Assumption of Lease • November 14th, 2003 • Nuvelo Inc • In vitro & in vivo diagnostic substances
THIS ASSIGNMENT AND ASSUMPTION OF LEASE (this “Assignment”) is entered into as of the 28 day of October, 2003 (the “Effective Date”), by NUVELO, INC., a Nevada corporation, successor by merger to Variagenics, Inc., a Delaware corporation (“Assignor”), and IDENIX PHARMACEUTICALS, INC., a Delaware corporation (“Assignee”).
